Latest News

A research team led by Dr. Dean Tang at Roswell Park Comprehensive Cancer Center has identified the molecule LRIG1 as an important endogenous tumor suppressor in prostate cancer.

Channels: All Journal News, Cancer, Men's Health, Pharmaceuticals, National Cancer Institute (NCI), Cancer Center Featured Story 2, Grant Funded News,

Keywords: Cancer, Cancer Research, Drug Development, Prostate Cancer, Cancer Therapeutics, Novel Therapies

The inventors of a cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, SurVaxM — a multimillion-dollar licensing deal that will help enable large, randomized clinical trials in both the U.S. and China.

Channels: All Journal News, Biotech, Cancer, Clinical Trials, Pharmaceuticals, China News, Cancer Center Featured Story 2,

Keywords: Brain Cancer, Immunotherapy, Cancer, Glioblastoma, Biotech

Roswell Park's Dr. Clare Twist led an effort to develop and validate a new treatment algorithm for infants and children with neuroblastoma. In a new study in the Journal of Clinical Oncology, the team reports that many patients can safely receive less extensive therapy.

Channels: All Journal News, Cancer, Children's Health, Cancer Center Featured Story 2, Grant Funded News,

Keywords: Cancer, Pediatric Cancer, Childhood Cancer, Cancer Research, Neuroblastoma, Algorithm

In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients with some head/neck and lung cancers.

Channels: Cancer, Pharmaceuticals, Cancer Center Featured Story 2, Medical Meetings,

Keywords: Aspirin, Nsaids, Radiation Therapy, Radiotherapy, Cancer Treatment, Cancer Research

A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a DoD grant that will fund a clinical trial in patients with brain-metastatic breast cancer.

Channels: Cancer, Immunology, Women's Health, Cancer Center Featured Story 2,

Keywords: Immunotherapy, Breast Cancer, Metastatic Breast Cancer, Cancer Treatment, Cancer Research

Roswell Park researchers have received recent grant awards totaling more than $15.4 million. These competitive awards include the first National Institutes of Health funding to study a new electronic tobacco device and a state grant supporting Roswell Park's work with the national Cancer Moonshot.

Channels: Budgets and Funding, Cancer, Cancer Center Featured Story 2,

Keywords: Cancer, Research Funding, Funding, Cancer Research, Prostate Cancer, Breast Cancer, TNBC, Tamoxifen, Cancer Moonshot, IQOS

Roswell Park researchers have uncovered a biomarker that may help explain why some patients respond better than others to sorafenib, a chemotherapy commonly prescribed for patients with advanced liver cancer.

Channels: Cancer, Immunology, Pharmaceuticals, Cancer Center Featured Story 2, All Journal News, Grant Funded News,

Keywords: Cancer, Liver Cancer, Sorafenib, Cancer Research, Immunotherapy, checkpoint inhibitors

Researchers from Roswell Park have developed a new bioinformatics-based approach for monitoring key changes in cancer cells — a data-driven method that might help to enhance and personalize cancer treatment.

Channels: All Journal News, Cancer, Genetics, Nature (journal), Cancer Center Featured Story 2, Grant Funded News,

Keywords: Cancer, Big Data, Bioinformatics, Genetics, Genomics, Cancer Research

A cancer therapy based on the work of Ben Seon, PhD, at Roswell Park Comprehensive Cancer Center has been approved by the U.S. Food and Drug Administration (FDA) for patients with an aggressive form of non-Hodgkin lymphoma.

Channels: Cancer, Immunology, Cancer Center Featured Story 2,

Keywords: Cancer, Lymphoma, Cancer Drug, FDA Approval, FDA, Drug Development

Jens Hillengass, MD, Chief of Myeloma at Roswell Park Comprehensive Cancer Center, led an International Myeloma Working Group (IMWG) effort to compile new recommendations for imaging techniques that offer more sensitive and accurate diagnosis and monitoring for patients with multiple myeloma and other plasma-cell disorders.

Channels: All Journal News, Blood, Cancer, Cancer Center Featured Story 2,

Keywords: Cancer, Myeloma, Multiple Myeloma, Guidelines, Imaging, CT, X-Ray, Radiology